Oxidative Stress, a Crossroad Between Rare Diseases and Neurodegeneration
Carmen Espinós,
Máximo Ibo Galindo,
María Adelaida García-Gimeno,
José Santiago Ibáñez-Cabellos,
Dolores Martínez-Rubio,
José María Millán,
Regina Rodrigo,
Pascual Sanz,
Marta Seco-Cervera,
Teresa Sevilla,
Andrea Tapia,
Federico V. Pallardó
Affiliations
Carmen Espinós
Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders, Centro de Investigación Príncipe Felipe (CIPF), 46012 Valencia, Spain
Máximo Ibo Galindo
Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, 46022 Valencia Spain
María Adelaida García-Gimeno
Department of Biotechnology, Escuela Técnica Superior de Ingeniería Agronómica y del Medio Natural (ETSIAMN), Universitat Politècnica de València, 46022 Valencia, Spain
José Santiago Ibáñez-Cabellos
Rare Diseases Joint Unit, CIPF-INCLIVA, 46010 Valencia, Spain
Dolores Martínez-Rubio
Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders, Centro de Investigación Príncipe Felipe (CIPF), 46012 Valencia, Spain
José María Millán
Rare Diseases Joint Unit, CIPF-IIS La Fe, 46026 Valencia, Spain
Regina Rodrigo
Rare Diseases Joint Unit, CIPF-IIS La Fe, 46026 Valencia, Spain
Pascual Sanz
Instituto de Biomedicina de Valencia (IBV)-CSIC Associated Unit, Centro de Investigación Príncipe Felipe (CIPF), 46010 Valencia, Spain
Marta Seco-Cervera
Rare Diseases Joint Unit, CIPF-INCLIVA, 46010 Valencia, Spain
Teresa Sevilla
Rare Diseases Joint Unit, CIPF-IIS La Fe, 46026 Valencia, Spain
Andrea Tapia
Laboratory of Developmental Biology and Disease Models, UPV-CIPF Joint Research Unit Disease Mechanisms and Nanomedicine, Centro de Investigación Príncipe Felipe, 46012 Valencia, Spain
Federico V. Pallardó
Rare Diseases Joint Unit, CIPF-INCLIVA, 46010 Valencia, Spain
: Oxidative stress is an imbalance between production and accumulation of oxygen reactive species and/or reactive nitrogen species in cells and tissues, and the capacity of detoxifying these products, using enzymatic and non-enzymatic components, such as glutathione. Oxidative stress plays roles in several pathological processes in the nervous system, such as neurotoxicity, neuroinflammation, ischemic stroke, and neurodegeneration. The concepts of oxidative stress and rare diseases were formulated in the eighties, and since then, the link between them has not stopped growing. The present review aims to expand knowledge in the pathological processes associated with oxidative stress underlying some groups of rare diseases: Friedreich’s ataxia, diseases with neurodegeneration with brain iron accumulation, Charcot-Marie-Tooth as an example of rare neuromuscular disorders, inherited retinal dystrophies, progressive myoclonus epilepsies, and pediatric drug-resistant epilepsies. Despite the discrimination between cause and effect may not be easy on many occasions, all these conditions are Mendelian rare diseases that share oxidative stress as a common factor, and this may represent a potential target for therapies.